Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: ADVANCED ACCELERATOR APPLICATIONS USA INC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2024-12-04 to 2025-12-04
Current total value of award: $498438.38
Description: SIX BRANDED NUCLEAR MEDICINE FDA APPROVED LUTATHERA AND PLUVICTO.